Synchron Launches Patient Registry for Stentrode Brain Computer Interface | Synchron
evtoday.com/news/synchron-…

Our team is heading to #ASNR24 ! Stop by our booth or join us for the Inaugural Implantable Brain Computer Interface ( #BCI ) Workshop with ASNR and BCI Society on Wednesday, April 10th. More info at asnr.com/asnr2024

Exclusive: Synchron, a rival to Musk’s Neuralink, readies large-scale brain implant trial reut.rs/4cK1rfv

We’re excited to announce the launch of our community-centered BCI registry to bring patients, carers and clinicians together to learn how #BCI is being designed to provide benefit to people with limited mobility. 🧠🧠

businesswire.com/news/home/2024…

Our CEO Thomas Oxley will keynote the Bioelectronic Medicine Forum on April 5th at 9am ET.

See the full agenda here: neurotechreports.com/pages/bmfagend…

.The Wall Street Journal speaks with our CEO & Founder Thomas Oxley about how #braincomputerinterfaces work.

Check out the demo of our BCI device and how it’s implanted in the brain: youtube.com/watch?v=3jwVBr…

Next on stage: Our CEO, Thomas Oxley and Andrew Rasdal, former Dexcom CEO and Synchron board member, will discuss the future of #Neurotechnology at #LSIUSA24 today at 7:30pm PST. LSI - Life Science Intelligence™

Event details here: lifesciencemarketresearch.com/medtech-summit…

In this WIRED article by Caitlin Kelly, Shahram Majidi, MD - a #neurosurgeon at Mount Sinai Neurosurgery - gives us a glimpse of what the future of #BCI could look like. 🧠🧠 wired.com/story/your-nex…

Honored to share that Synchron is a member of the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC). We’re proud to be driving patient-first innovation in #BCI alongside our fellow signatories. businesswire.com/news/home/2024…

For insight into how a pre-revenue #BCI company approaches reimbursement strategy at this stage, our Chief Commercial Officer Kurt Haggstrom speaks with @forbes columnist Naveen Rao forbes.com/sites/naveenra…

We were joined by Thomas Oxley Thomas Oxley (CEO, Synchron) on the #DeepFest24 stage for his talk on 'Neurotechnology to Unlock the Brain'.

Thanks @cnn Dr. Sanjay Gupta for speaking with Mark! #BCI 🧠

cnn.com/2024/02/28/tec…

One of the first ⁦Synchron patients, profiled on ⁦CNN⁩ showing how he is using his (minimally invasively placed) intravascular brain-computer interface to interact with the world.

.CNN feature on @Synchron's brain computer interface #Strentrode  👇

Mark showing the world how to use a BCI amp-cnn-com.cdn.ampproject.org/c/s/amp.cnn.co…

We are excited to welcome Thomas Oxley, CEO of Synchron at Mount Sinai Hospital, as a speaker at #LEAP24 .

Oxley is the CEO and founder of Synchron, a company building next-generation brain-computer interface solutions.

With extensive expertise as a vascular and interventional…

What's CEO Thomas Oxley curious about? Check out the latest episode of NYSE 🏛 The Cure(ious) to find out.

Step into the future of neurotechnology at #LSIUSA24 . Our latest Fireside Chat, “Neurotechnology to Address the Limitations of the Human Body”, features Thomas Oxley, CEO of Synchron, and Andrew Rasdal, Former Dexcom CEO and Board Director at Synchron.